[1] 周岳进. 替比夫定对拉米夫定和阿德福韦酯耐药的慢性乙型肝炎疗效观察[J]. 肝脏,2009,14:80-81. [2] DIBISCEGLIE A,LAI CL,GANE E,et al. Telbivudine Clobe trial:maximal early HBV suppression is predicitive of optimal two-year efficacy in nucleoside-treated hepatient[J]. Hepatology,2006,44:230A. [3] 张林,张大志,陈敏,等. 替比夫定治疗期间外围血Th1/Th2型细胞因子水平的动态变化情况[J]. 中华肝脏病杂志,2009,17:175-179. [4] 陈新月,吴亚松,马丽娜,等. 替比夫定单药或联合干扰素治疗慢性乙型肝炎并发周围神经炎临床分析[J]. 中华传染病杂志,2009,27:53-55. [5] EMMET B,KEEFFE EB,DOUGLAS T,et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States[J]. Clin Gastroenterol Hepatol,2008,6:1315-1341. [6] PINTI M,SALOMONI P,COSSARIZZA A. Anti-HIV drug and the mitochondria[J]. Biochim Biophys Acta,2006,1757:700-703. [7] LAI CL,GANE E,LIAU YF,et al. Telbivudine versus lamivudine in patients with hepatitis B[J]. N Engl J Med, 2007,357:2576-2588. |